Your browser doesn't support javascript.
loading
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.
Salaroglio, Iris Chiara; Belisario, Dimas Carolina; Bironzo, Paolo; Ananthanarayanan, Preeta; Ricci, Luisa; Digiovanni, Sabrina; Fontana, Simona; Napoli, Francesca; Sandri, Alberto; Facolmatà, Chiara; Libener, Roberta; Comunanza, Valentina; Grosso, Federica; Gazzano, Elena; Leo, Francesco; Taulli, Riccardo; Bussolino, Federico; Righi, Luisella; Papotti, Mauro Giulio; Novello, Silvia; Scagliotti, Giorgio Vittorio; Riganti, Chiara; Kopecka, Joanna.
Afiliação
  • Salaroglio IC; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Belisario DC; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Bironzo P; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Ananthanarayanan P; Thoracic Unit and Medical Oncology Division, Department of Oncology at San Luigi Hospital, University of Torino, Orbassano, Italy.
  • Ricci L; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Digiovanni S; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Fontana S; Present address: IRCCS San Raffaele Hospital DIBIT, 20132, Milano, Italy.
  • Napoli F; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Sandri A; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Facolmatà C; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Libener R; Pathology Unit, San Luigi Hospital, University of Torino, Orbassano, Italy.
  • Comunanza V; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Grosso F; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Gazzano E; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Leo F; Present address: German Cancer Research Center (DKFZ) and Technical University Munich, 81675, Munich, Germany.
  • Taulli R; Department of Integrated Activities Research and Innovation, S. Antonio and Biagio Hospital, Alessandria, Italy.
  • Bussolino F; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Righi L; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Papotti MG; Oncology Division, S. Antonio and Biagio Hospital, Alessandria, Italy.
  • Novello S; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
  • Scagliotti GV; Interdepartmental Research Center of Molecular Biotechnology, University of Torino, Torino, Italy.
  • Riganti C; Present address: Department of Life Sciences and Systems Biology, University of Torino, 10123, Torino, Italy.
  • Kopecka J; Department of Oncology, University of Torino, via Santena 5/bis, 10126, Torino, Italy.
J Exp Clin Cancer Res ; 41(1): 75, 2022 Feb 23.
Article em En | MEDLINE | ID: mdl-35197103
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Proteínas Quinases Associadas a Fase S / Inibidores Enzimáticos / Pemetrexede / Mesotelioma Maligno / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cisplatino / Proteínas Quinases Associadas a Fase S / Inibidores Enzimáticos / Pemetrexede / Mesotelioma Maligno / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2022 Tipo de documento: Article